Marcie A. Goldstein
Lawyers
Represents broker-dealers and issuers on securities law compliance and FINRA requirements.
Marcie represents broker-dealers and issuers in connection with public and private securities offerings, mergers and other corporate transactions with respect to compliance with state securities laws and FINRA requirements.
Experience highlights
Recent Representations
- Bumble $313.5 million secondary offering
- Mirion Technologies $85.6 million secondary offering
- Revolution Medicines $345 million follow-on offering
- Alight $476 million secondary offering
- Sun Country Airlines $103.69 million secondary offering
- Deutsche Bank $1.5 billion subordinated Tier 2 notes offering
- Morgan Stanley AIP closes $2.5 billion secondaries fund
- Terns Pharmaceuticals $86 million stock offering
- Prometheus Biosciences $500 million follow-on offering
- Shoals Technologies Group $665 million stock offering
- FREYR Battery $264.5 million debut public share offering
- Alight $178 million debut secondary offering
- Akoya Biosciences $50 million at-the-market program
- Prime Medicine $175 million IPO
- Gamida Cell $20 million follow-on offering
- Alignment Healthcare $132.75 million secondary offering
Education
J.D., Wayne State University Law School
B.A., University of Michigan
- with honors
Professional history
- Counsel, 1988-present
- Davis Polk since 1983
- Examiner, Michigan Corporation & Securities Bureau, 1980-1981
- Assistant Director, Corporate Financing, National Association of Securities Dealers, 1982-1983
Qualifications and admissions
- State of New York